OCM
JAZZ icon

Orser Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Orser Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,783
Closed -$883K – 97
2021
Q3 		$883K Buy
+6,783
New +$1.02M 0.49% 56

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Orser Capital Management's JAZZ Position: Q4 2021 in Review

Orser Capital Management sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2021, closing a stake of 6,783 shares — an estimated $883K sold.

Orser Capital Management first reported a position in JAZZ in Q3 2021 and held it in 1 quarter. The position peaked at $883K in Q3 2021. 454 funds tracked by Wall St. Rank hold JAZZ as of Q4 2021.

  • Orser Capital Management reported no remaining Jazz Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Orser Capital Management sold 6,783 Jazz Pharmaceuticals shares in Q4 2021, an estimated $883K.
  • Orser Capital Management first reported a position in Jazz Pharmaceuticals in Q3 2021 and held it in 1 quarter.
  • Orser Capital Management's Jazz Pharmaceuticals position peaked at $883K in Q3 2021.
  • 454 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2021.

Based on Orser Capital Management's 13F filing for Q4 2021, filed 19 Jan 2022.